While the role of CD8+ T cells in mediating response to cancer 1 immunotherapy is well established, the role of B cells remains 2 more controversial (1-3). By conducting a large gene expres-3 sion study of response to immune checkpoint inhibitors (ICI), 4 we show that pre-treatment expression of B cell genes is associ-5 ated with ICI response independently of CD8+ T cells. However, 6 we discovered that such association can be completely explained 7 by a single gene (FDCSP) expressed outside of the B cell com-8 partment, in fibroblastic reticular cells (FRCs), which form the 9 reticular network that facilitates interactions between B cells, 10 T cells and cognate antigens (4-6) and are required to initiate 11 efficient adaptive immune responses in secondary lymphoid or-12 gans (SLO) and tertiary lymphoid structures (TLS) (4, 7). We 13 validated this finding in three independent cohorts of patients 14 treated with ICI in melanoma and renal cell carcinoma. Taken 15 together, these results suggest that FDCSP is an independent 16 predictor of ICI response, thus opening new avenues to explain 17 the mechanisms of resistance to cancer immunotherapy.
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and are also reported in Table S7 . A red background highlights effect sizes estimated to be greater than zero with FDR < 0.05. In this study, an effect size greater than zero represents a positive association between gene expression and probability of ICI response. E-G Association between pre-treatment expression of FDCSP and subsequent ICI response in the first (25), second (8) and third validation cohort (26). See supplementary methods. Single-cell RNAseq: differentially expressed genes. Expression values obtained from GSE127465 and GSE115978 were transformed in logarithmic scale (y = log 2 (x + 1)). Cells annotated as fibroblasts in the original study were selected and 282 used to compare fibroblasts expressing FDCSP (FDCSP+) against fibroblasts not expressing FDCSP (FDCSP-). Statistical 283 significance for gene expression differences observed between these two groups was assessed using unpaired two-samples 284 Wilcoxon test (29). Genes were ranked using a numerical score which takes into account both p-value and log 2 (f c): score 285 = − log 10 (p − value) * | log 2 (f c)| * sign(log 2 (f c)). Results for GSE127465 (non-small cell lung cancer) and GSE115978 286 (melanoma) were meta-analysed using the RankProduct method (30, 31) and are presented in Tables S5 and S6 .
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Code availability. The authors declare that the code used for this study is available upon request. 185-198 (1972) . Table S6 | Top 50 genes down-regulated in FDCSP+ fibroblasts compared to FDCSP-fibroblasts detected by using single-cell RNAseq data. Differential gene expression analysis comparing single-cell transcriptomes of FDCSP+ fibroblasts versus FDCSP-fibroblasts obtained from lung cancer (NSCLC) and melanoma tumours (MEL). The analysis was performed using gene expression data published in (25, 27) . Results from both datasets were meta-analysed using the RankProduct method (RP; see supplementary methods). The complete list is provided in a separate spreadsheet file (FDCSP_pos_vs_FDCSP_neg_fibroblasts.xlsx). 
